These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25966432)

  • 1. The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma.
    Howell M; Valle JW
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):333-43. PubMed ID: 25966432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of adjuvant therapy after R0 resection for patients with intrahepatic and perihilar cholangiocarcinomas.
    Kim YS; Oh SY; Go SI; Kang JH; Park I; Song HN; Ji JH; Hwang IG; Jang JS
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):99-106. PubMed ID: 27928598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
    Rizzo A; Brandi G
    Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic adjuvant chemotherapy for cholangiocarcinoma surgery: A systematic review and meta-analysis.
    Rangarajan K; Simmons G; Manas D; Malik H; Hamady ZZ
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):684-693. PubMed ID: 31761507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the role of adjuvant therapy: cholangiocarcinoma and gall bladder cancer.
    Williams TM; Majithia L; Wang SJ; Thomas CR
    Semin Radiat Oncol; 2014 Apr; 24(2):94-104. PubMed ID: 24635866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.
    Oguz S; Kucukaslan H; Topaloglu S; Ones T; Baltacioglu F; Cobanoglu U; Calik A
    J Gastrointest Cancer; 2021 Mar; 52(1):342-346. PubMed ID: 32617830
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG; Walter T; Horgan AM; Amir E; Cleary S; McKeever EL; Min T; Wallace E; Hedley D; Krzyzanowska M; Moore M; Gallinger S; Greig P; Serra S; Dawson LA; Knox JJ
    Am J Clin Oncol; 2015 Aug; 38(4):382-7. PubMed ID: 24572429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins.
    Glazer ES; Liu P; Abdalla EK; Vauthey JN; Curley SA
    J Gastrointest Surg; 2012 Sep; 16(9):1666-71. PubMed ID: 22777053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnosis and treatment of cholangiocarcinoma.
    Vogel A; Wege H; Caca K; Nashan B; Neumann U
    Dtsch Arztebl Int; 2014 Oct; 111(44):748-54. PubMed ID: 25412632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy for Biliary Tract Cancers.
    Horgan AM; Knox JJ
    J Oncol Pract; 2018 Dec; 14(12):701-708. PubMed ID: 30537458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.
    Skipworth JR; Olde Damink SW; Imber C; Bridgewater J; Pereira SP; Malagó M
    Aliment Pharmacol Ther; 2011 Nov; 34(9):1063-78. PubMed ID: 21933219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic advances in the management of biliary tract carcinoma].
    Ribiere SC; Léandri C; Guillaumot MA; Brezault C; Coriat R
    Presse Med; 2018 May; 47(5):419-422. PubMed ID: 29622390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy in cholangiocellular carcinomas.
    Brunner TB; Seufferlein T
    Best Pract Res Clin Gastroenterol; 2016 Aug; 30(4):593-602. PubMed ID: 27644907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current role of radiotherapy and systemic therapy in the multidisciplinary treatment of cholangiocarcinoma.
    Soumarová R; Gürlich R; Hajer J; Oliverius M; Kubecová M; Šejdová M; Liberko M; Kološtová K
    Cas Lek Cesk; 2019; 158(2):78-82. PubMed ID: 31109168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment.
    Cholangiocarcinoma Working Group
    Dig Liver Dis; 2020 Dec; 52(12):1430-1442. PubMed ID: 32952071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy.
    Serafini FM; Sachs D; Bloomston M; Carey LC; Karl RC; Murr MM; Rosemurgy AS
    Am Surg; 2001 Sep; 67(9):839-43; discussion 843-4. PubMed ID: 11565760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.